| 0 |
CONGENITAL DYSFIBRINOGENAEMIA |
2 |
0.1667 |
| 1 |
HAEMORRHAGE FOETAL |
3 |
0.0566 |
| 2 |
HEPATITIS B E ANTIBODY POSITIVE |
1 |
0.0455 |
| 3 |
FOETAL-MATERNAL HAEMORRHAGE |
2 |
0.0417 |
| 4 |
PLEURAL INFECTION BACTERIAL |
1 |
0.0256 |
| 5 |
PORTAL VEIN CAVERNOUS TRANSFORMATION |
1 |
0.0244 |
| 6 |
FOETAL ANAEMIA |
3 |
0.0229 |
| 7 |
INHIBITING ANTIBODIES POSITIVE |
1 |
0.0175 |
| 8 |
VISCERAL VENOUS THROMBOSIS |
1 |
0.0167 |
| 9 |
PORTOSPLENOMESENTERIC VENOUS THROMBOSIS |
1 |
0.0164 |
| 10 |
VIRAL CARDIOMYOPATHY |
1 |
0.0127 |
| 11 |
ANAEMIA FOLATE DEFICIENCY |
2 |
0.0104 |
| 12 |
SHUNT THROMBOSIS |
1 |
0.0101 |
| 13 |
ACINETOBACTER TEST POSITIVE |
1 |
0.0052 |
| 14 |
RENAL GRAFT INFECTION |
1 |
0.0043 |
| 15 |
TRANSFUSION-RELATED CIRCULATORY OVERLOAD |
1 |
0.0041 |
| 16 |
BUDD-CHIARI SYNDROME |
1 |
0.0040 |
| 17 |
INFUSION SITE THROMBOSIS |
1 |
0.0037 |
| 18 |
GASTROINTESTINAL ISCHAEMIA |
1 |
0.0036 |
| 19 |
HEPATITIS B SURFACE ANTIBODY POSITIVE |
1 |
0.0034 |
| 20 |
TRANSFUSION-RELATED ACUTE LUNG INJURY |
1 |
0.0032 |
| 21 |
HEPATIC VEIN THROMBOSIS |
1 |
0.0032 |
| 22 |
HEPATITIS B CORE ANTIBODY POSITIVE |
1 |
0.0027 |
| 23 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
2 |
0.0022 |
| 24 |
HYPOPROTEINAEMIA |
4 |
0.0021 |
| 25 |
IMMUNE-MEDIATED ENCEPHALITIS |
1 |
0.0019 |
| 26 |
JUGULAR VEIN DISTENSION |
1 |
0.0018 |
| 27 |
GRAFT COMPLICATION |
1 |
0.0017 |
| 28 |
ACUTE LEFT VENTRICULAR FAILURE |
1 |
0.0015 |
| 29 |
CAPILLARY LEAK SYNDROME |
3 |
0.0014 |
| 30 |
HAEMORRHAGE IN PREGNANCY |
2 |
0.0014 |
| 31 |
TONSIL CANCER |
1 |
0.0012 |
| 32 |
POUCHITIS |
1 |
0.0012 |
| 33 |
BLOOD ALKALINE PHOSPHATASE DECREASED |
1 |
0.0011 |
| 34 |
RED BLOOD CELLS URINE POSITIVE |
1 |
0.0010 |
| 35 |
CONTINUOUS HAEMODIAFILTRATION |
1 |
0.0010 |
| 36 |
HYPOFIBRINOGENAEMIA |
1 |
0.0010 |
| 37 |
BRAIN DEATH |
3 |
0.0010 |
| 38 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
2 |
0.0009 |
| 39 |
ACINETOBACTER INFECTION |
1 |
0.0009 |
| 40 |
HYPOCHLORAEMIA |
1 |
0.0009 |
| 41 |
CEREBRAL ARTERY EMBOLISM |
1 |
0.0008 |
| 42 |
MONOCYTE COUNT DECREASED |
1 |
0.0008 |
| 43 |
POSTPARTUM HAEMORRHAGE |
1 |
0.0007 |
| 44 |
HYPERURICAEMIA |
3 |
0.0007 |
| 45 |
HEPATITIS ACUTE |
4 |
0.0006 |
| 46 |
ENTEROBACTER INFECTION |
1 |
0.0006 |
| 47 |
TREATMENT DELAYED |
1 |
0.0006 |
| 48 |
THROMBOPHLEBITIS |
2 |
0.0006 |
| 49 |
AORTIC VALVE STENOSIS |
1 |
0.0006 |
| 50 |
PNEUMOMEDIASTINUM |
1 |
0.0006 |
| 51 |
SMALL INTESTINAL PERFORATION |
1 |
0.0005 |
| 52 |
HYPOALBUMINAEMIA |
4 |
0.0005 |
| 53 |
VENOUS THROMBOSIS |
2 |
0.0005 |
| 54 |
FOETAL GROWTH RESTRICTION |
3 |
0.0005 |
| 55 |
BLOOD LOSS ANAEMIA |
1 |
0.0004 |
| 56 |
INTRA-ABDOMINAL HAEMORRHAGE |
1 |
0.0004 |
| 57 |
HYPERNATRAEMIA |
2 |
0.0004 |
| 58 |
LYMPHOCYTE COUNT DECREASED |
7 |
0.0004 |
| 59 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
11 |
0.0004 |
| 60 |
COMPARTMENT SYNDROME |
1 |
0.0004 |
| 61 |
PARTIAL SEIZURES |
2 |
0.0004 |
| 62 |
SUBDURAL HAEMATOMA |
5 |
0.0003 |
| 63 |
HAEMOTHORAX |
1 |
0.0003 |
| 64 |
GASTROINTESTINAL NECROSIS |
1 |
0.0003 |
| 65 |
STRIDOR |
1 |
0.0003 |
| 66 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0003 |
| 67 |
PIGMENTATION DISORDER |
2 |
0.0003 |
| 68 |
HIGH DENSITY LIPOPROTEIN DECREASED |
1 |
0.0003 |
| 69 |
WOUND COMPLICATION |
1 |
0.0003 |
| 70 |
POOR VENOUS ACCESS |
3 |
0.0003 |
| 71 |
HAEMORRHAGIC DIATHESIS |
1 |
0.0003 |
| 72 |
MYELODYSPLASTIC SYNDROME |
4 |
0.0003 |
| 73 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
2 |
0.0003 |
| 74 |
CYTOKINE RELEASE SYNDROME |
5 |
0.0002 |
| 75 |
SHOCK HAEMORRHAGIC |
2 |
0.0002 |
| 76 |
ESCHERICHIA INFECTION |
2 |
0.0002 |
| 77 |
ANAPHYLACTOID REACTION |
1 |
0.0002 |
| 78 |
CYTOMEGALOVIRUS VIRAEMIA |
1 |
0.0002 |
| 79 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 80 |
EYE OPERATION |
1 |
0.0002 |
| 81 |
HYPOCALCAEMIA |
4 |
0.0002 |
| 82 |
BODY TEMPERATURE DECREASED |
2 |
0.0002 |
| 83 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 84 |
NORMAL NEWBORN |
1 |
0.0002 |
| 85 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 86 |
PREMATURE LABOUR |
1 |
0.0002 |
| 87 |
HEPATITIS B |
1 |
0.0002 |
| 88 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 89 |
SWELLING OF EYELID |
1 |
0.0002 |
| 90 |
ANAPHYLACTIC SHOCK |
4 |
0.0002 |
| 91 |
HIATUS HERNIA |
2 |
0.0002 |
| 92 |
ASPERGILLUS INFECTION |
1 |
0.0002 |
| 93 |
DYSGRAPHIA |
1 |
0.0002 |
| 94 |
APPETITE DISORDER |
1 |
0.0002 |
| 95 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 96 |
DEFAECATION URGENCY |
1 |
0.0001 |
| 97 |
HEPATOCELLULAR INJURY |
2 |
0.0001 |
| 98 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 99 |
ASCITES |
4 |
0.0001 |
| 100 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 101 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 102 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 103 |
NEUTROPHIL COUNT DECREASED |
5 |
0.0001 |
| 104 |
COAGULOPATHY |
2 |
0.0001 |
| 105 |
LIVE BIRTH |
1 |
0.0001 |
| 106 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 107 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 108 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 109 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 110 |
SINUS BRADYCARDIA |
1 |
0.0001 |
| 111 |
INFLAMMATORY BOWEL DISEASE |
1 |
0.0001 |
| 112 |
PREMATURE BABY |
3 |
0.0001 |
| 113 |
MOTOR DYSFUNCTION |
1 |
0.0001 |
| 114 |
MOUTH ULCERATION |
2 |
0.0001 |
| 115 |
ASPARTATE AMINOTRANSFERASE INCREASED |
5 |
0.0001 |
| 116 |
SKIN LACERATION |
1 |
0.0001 |
| 117 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
| 118 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 119 |
PRODUCT AVAILABILITY ISSUE |
2 |
0.0001 |
| 120 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 121 |
HYPOKALAEMIA |
4 |
0.0001 |
| 122 |
EYELID OEDEMA |
1 |
0.0001 |
| 123 |
DISEASE RECURRENCE |
4 |
0.0001 |
| 124 |
C-REACTIVE PROTEIN INCREASED |
3 |
0.0001 |
| 125 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 126 |
PLEURAL EFFUSION |
5 |
0.0001 |
| 127 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 128 |
PHARYNGITIS |
1 |
0.0001 |
| 129 |
HEPATIC FUNCTION ABNORMAL |
3 |
0.0001 |
| 130 |
LEUKOPENIA |
4 |
0.0001 |
| 131 |
HAEMATOMA |
2 |
0.0001 |
| 132 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 133 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 134 |
ABORTION SPONTANEOUS |
3 |
0.0001 |
| 135 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 136 |
FOETAL EXPOSURE DURING PREGNANCY |
6 |
0.0001 |
| 137 |
WHITE BLOOD CELL COUNT DECREASED |
8 |
0.0001 |
| 138 |
TACHYPNOEA |
1 |
0.0001 |
| 139 |
PROCEDURAL PAIN |
2 |
0.0001 |
| 140 |
HYPOMAGNESAEMIA |
1 |
0.0001 |
| 141 |
HYPOTENSION |
14 |
0.0001 |
| 142 |
SEPTIC SHOCK |
3 |
0.0001 |
| 143 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 144 |
MATERNAL EXPOSURE DURING PREGNANCY |
6 |
0.0001 |
| 145 |
HEPATIC FAILURE |
2 |
0.0001 |
| 146 |
EPILEPSY |
2 |
0.0001 |
| 147 |
ALANINE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 148 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 149 |
PNEUMOTHORAX |
1 |
0.0001 |
| 150 |
PREMATURE DELIVERY |
1 |
0.0001 |
| 151 |
DEEP VEIN THROMBOSIS |
4 |
0.0001 |
| 152 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 153 |
BLOOD PRESSURE DECREASED |
4 |
0.0001 |
| 154 |
FACE OEDEMA |
1 |
0.0001 |
| 155 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 156 |
HYPERKALAEMIA |
2 |
0.0001 |
| 157 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 158 |
MYELOSUPPRESSION |
2 |
0.0001 |
| 159 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 160 |
ANAPHYLACTIC REACTION |
3 |
0.0001 |
| 161 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 162 |
HAEMORRHOIDS |
1 |
0.0001 |
| 163 |
ORAL HERPES |
1 |
0.0001 |
| 164 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 165 |
CARDIO-RESPIRATORY ARREST |
2 |
0.0000 |
| 166 |
ANAEMIA |
9 |
0.0000 |
| 167 |
PLATELET COUNT DECREASED |
5 |
0.0000 |
| 168 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 169 |
MELAENA |
1 |
0.0000 |
| 170 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 171 |
SHOCK |
1 |
0.0000 |
| 172 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 173 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 174 |
BRADYCARDIA |
2 |
0.0000 |
| 175 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0000 |
| 176 |
BLISTER |
2 |
0.0000 |
| 177 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 178 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 179 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 180 |
HYPERTENSION |
7 |
0.0000 |
| 181 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 182 |
PULMONARY EMBOLISM |
3 |
0.0000 |
| 183 |
CYSTITIS |
1 |
0.0000 |
| 184 |
LACTIC ACIDOSIS |
1 |
0.0000 |
| 185 |
HEART RATE INCREASED |
3 |
0.0000 |
| 186 |
HAEMATURIA |
1 |
0.0000 |
| 187 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 188 |
SEPSIS |
3 |
0.0000 |
| 189 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 190 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 191 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 192 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 193 |
THROMBOSIS |
2 |
0.0000 |
| 194 |
PNEUMONIA |
8 |
0.0000 |
| 195 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 196 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 197 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 198 |
ANGIOEDEMA |
1 |
0.0000 |
| 199 |
TACHYCARDIA |
2 |
0.0000 |
| 200 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 201 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 202 |
SWELLING |
2 |
0.0000 |
| 203 |
ARRHYTHMIA |
1 |
0.0000 |
| 204 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 205 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 206 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 207 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 208 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 209 |
COVID-19 |
3 |
0.0000 |
| 210 |
DYSPHONIA |
1 |
0.0000 |
| 211 |
CHILLS |
2 |
0.0000 |
| 212 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 213 |
CATARACT |
1 |
0.0000 |
| 214 |
BLOOD CREATININE INCREASED |
1 |
0.0000 |
| 215 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 216 |
NEUTROPENIA |
2 |
0.0000 |
| 217 |
PYREXIA |
5 |
0.0000 |
| 218 |
INFECTION |
2 |
0.0000 |
| 219 |
DIABETES MELLITUS |
1 |
0.0000 |
| 220 |
OFF LABEL USE |
11 |
0.0000 |
| 221 |
URTICARIA |
2 |
0.0000 |
| 222 |
ANXIETY |
3 |
0.0000 |
| 223 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 224 |
DYSPEPSIA |
1 |
0.0000 |
| 225 |
SYNCOPE |
1 |
0.0000 |
| 226 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 227 |
DRUG INEFFECTIVE |
12 |
0.0000 |
| 228 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 229 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 230 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 231 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 232 |
RENAL FAILURE |
1 |
0.0000 |
| 233 |
RASH |
3 |
0.0000 |
| 234 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 235 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 236 |
DIZZINESS |
3 |
0.0000 |
| 237 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 238 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 239 |
CHEST PAIN |
1 |
0.0000 |
| 240 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 241 |
ASTHENIA |
2 |
0.0000 |
| 242 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 243 |
ERYTHEMA |
1 |
0.0000 |
| 244 |
ABDOMINAL PAIN UPPER |
1 |
0.0000 |
| 245 |
DIARRHOEA |
3 |
0.0000 |
| 246 |
OVERDOSE |
1 |
0.0000 |
| 247 |
VOMITING |
2 |
0.0000 |
| 248 |
COUGH |
1 |
0.0000 |
| 249 |
DYSPNOEA |
2 |
0.0000 |
| 250 |
DEATH |
3 |
0.0000 |
| 251 |
FALL |
1 |
0.0000 |
| 252 |
PRURITUS |
1 |
0.0000 |
| 253 |
FATIGUE |
2 |
0.0000 |
| 254 |
MALAISE |
1 |
0.0000 |
| 255 |
NAUSEA |
1 |
0.0000 |